Poncelet Alain J, Cornet Julien, Coulon Corinne, Collard Philippe, Noirhomme Philippe, Weynand Birgit
Department of Cardio-Vascular and Thoracic Surgery, UCL Saint Luc Hospital, Brussels, Belgium.
Eur J Cardiothorac Surg. 2008 May;33(5):799-804. doi: 10.1016/j.ejcts.2008.01.060.
In recent studies focusing on the prognostic significance of histologic features of NSCLC tumors, vessel invasion was correlated to survival across all surgical stages. We similarly analyzed whether intra-tumoral permeation could affect survival in subgroups of stage I and II NSCLC.
A retrospective single institution analysis of a prospectively computed database. Specimens were analyzed for intra-tumoral vascular, lymphatic and nervous permeation. Overall mortality was determined and for each stage, a Cox regression analysis of selected variables was performed. Detailed histologic information was available in all patients. Follow-up was 100% complete (median=69 months).
From 1989 to 2004, out of 346 patients with stage I and II NSCLC, 253 patients with p stage I (75.7%) and 81 patients with p stage II (24.3%) underwent surgery with complete resection, for a completeness resection rate of 97% (334/346). We performed 70 pneumonectomies, 255 lobectomies and 9 lesser resections (respectively, 21%, 76.3% and 2.7%). In-hospital mortality was 2.1%. The incidence of intra-tumoral permeation was 14.4% (48/334). Permeation correlated both with T status (p=0.04), grade of differentiation (p=0.03) and stage (p=0.02). Median survival and overall 5-year survival for patients with and without permeation were 42.3 months (95% CI [20-64.6]) and 72.1 months (95% CI [56.9-87.2]), respectively; and 44% and 54%, respectively (p=NS). However, intra-tumoral permeation was not a significant predictor for overall death (HR=1.1 [95% CI=0.74-1.66).
In this large institutional study of early stage NSCLC, the presence of intra-tumoral permeation was correlated both to T, grade of differentiation, as well as to stage. However, in contrast to recent reports, we did not find that intra-tumoral permeation adversely affects long-term survival.
在近期关注非小细胞肺癌(NSCLC)肿瘤组织学特征预后意义的研究中,血管侵犯与所有手术分期患者的生存率相关。我们同样分析了肿瘤内浸润是否会影响I期和II期NSCLC亚组患者的生存率。
对一个前瞻性计算机数据库进行单机构回顾性分析。对标本进行肿瘤内血管、淋巴管和神经浸润分析。确定总死亡率,并对每个分期的选定变量进行Cox回归分析。所有患者均有详细的组织学信息。随访率为100%(中位数=69个月)。
1989年至2004年,346例I期和II期NSCLC患者中,253例pI期患者(占75.7%)和81例pII期患者(占24.3%)接受了根治性手术切除,根治性切除率为97%(334/346)。我们进行了70例全肺切除术、255例肺叶切除术和9例较小范围的切除术(分别占21%、76.3%和2.7%)。住院死亡率为2.1%。肿瘤内浸润发生率为14.4%(48/334)。浸润与T分期(p=0.04)、分化程度(p=0.03)和分期(p=0.02)均相关。有浸润和无浸润患者的中位生存期和5年总生存率分别为42.3个月(95%CI[20-64.6])和72.1个月(95%CI[56.9-87.2]);分别为44%和54%(p=无统计学意义)。然而,肿瘤内浸润并非总死亡的显著预测因素(HR=1.1[95%CI=0.74-1.66])。
在这项关于早期NSCLC的大型机构研究中,肿瘤内浸润的存在与T分期、分化程度以及分期均相关。然而,与近期报道相反,我们并未发现肿瘤内浸润会对长期生存产生不利影响。